Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-02-08
2005-02-08
Nguyen, Dave T. (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S184100, C424S278100, C424S283100, C435S320100, C536S023720
Reexamination Certificate
active
06852705
ABSTRACT:
Improved vaccines or immunogenic or immunological compositions, and methods for making and using the same.
REFERENCES:
patent: 4946787 (1990-08-01), Eppstein et al.
patent: 5106733 (1992-04-01), Baker et al.
patent: 5459127 (1995-10-01), Felgner et al.
patent: 5545412 (1996-08-01), Eppstein et al.
patent: 5548412 (1996-08-01), Minamizawa et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5620896 (1997-04-01), Herrmann et al.
patent: 5643578 (1997-07-01), Robinson et al.
patent: 5703055 (1997-12-01), Felgner et al.
patent: 5705385 (1998-01-01), Bally et al.
patent: 5719131 (1998-02-01), Harris et al.
patent: 5846946 (1998-12-01), Huebner et al.
patent: 5910488 (1999-06-01), Nabel et al.
patent: 6019980 (2000-02-01), Li et al.
patent: 6187759 (2001-02-01), Tarpey et al.
patent: 6287856 (2001-09-01), Poet et al.
patent: 6376473 (2002-04-01), Audonnet et al.
patent: 6451770 (2002-09-01), Rijsewijk et al.
patent: 737 750 (1990-03-01), None
patent: WO 90 11092 (1990-10-01), None
patent: WO 92 05255 (1992-04-01), None
patent: WO 93 19183 (1993-09-01), None
patent: WO 9401133 (1994-01-01), None
patent: WO 94 21797 (1994-09-01), None
patent: WO 9427435 (1994-12-01), None
patent: WO 9520660 (1995-08-01), None
patent: WO 96 06619 (1996-03-01), None
patent: WO 9634109 (1996-10-01), None
patent: WO 96 40945 (1996-12-01), None
patent: WO 9640945 (1996-12-01), None
patent: WO 97 23502 (1997-07-01), None
patent: WO 9740163 (1997-10-01), None
patent: WO 9741236 (1997-11-01), None
patent: WO 98 02179 (1998-01-01), None
patent: WO 9840499 (1998-09-01), None
patent: WO 00 24428 (2000-05-01), None
patent: WO 0152888 (2001-07-01), None
Klavinskis et al. (Journal of Immunol. vol. 162, No. 1., pp. 254-262; Jan. 1, 1999).*
Taylor G. et al. Recombinant vaccinia viruses expressing the F, G or N, but not the M2, protein of BRSV induce resistance to BRSV challange in the calf . . . J. Gen. Virol. 1997; vol. 78, p. 3195-3206.*
Gao Yi et al., “Truncated B vine Herpesvirus-1 Glycoprotein I (gpI) Initiates a Protective Local Immune Response in its Natural Host.” Vaccine, GB, Butterworth Scientific. Guilford; vol. 12, No. 2, 1994, pps. 145-152.
Wheeler, C.J. et al., “Converting an Alcohol 1-40 to an Amine in a Cationic Lipid Dramatically Alters to Co-Lipid Requirement, Cellular Transfection Activity and the Ultrastructure of DNA-Cytofectin Complexes”; Biochimica Et Biophysica Acta, NL, Amsterdam; vol. 1280, No. 1, 1996, pps 1-11.
Felgner J.H. et al., “Enhanced Gene Delivery and Mechanism Studies with a Novel Series of Cationic Lipid Formulations”; Journal of Biological Chemistry, U.S., American Society of Biological Chemists, Baltimore, MD, vol. 269, No. 4, Jan. 28, 1994, pps. 2550-2561.
Li Xiaomao et al, “Protection Against Respiratory Syncytial Virus Infection by DNA Immunization”; Journal of Experimental Medcine, Tokyo, JP, vol. 188, No. 4, Aug. 17, 1998, pps. 681-688.
Cox, GJM, et al. “Bovine Herpesvirus 1: Immune Responses in Mice and Cattle Injected with Plasmid DNA” J. Virol 1993, vol. 67, No. 9:5664-5667.
Hartikka, J, et al. “An Improved Plamid DNA Expression Vector for Direct Injection into Skeletal Muscle” Human Gene Therapy 1996, vol. 7:1205-1217.
Manthorpe, M., et al. “Gene Therapy by Intramuscular Injection of Plasmid DNA” Studies on Firefly Luciferase Gene Expression in Mice Human Gene Therapy 1993, vol. 4:419-431.
Bourne, N., et al. “DNA Immunization against Experimental Genital Herpes Simplex Virus Infection” The Journal of Infectious Diseases 1996, vol. 173:800-807.
Ertl, H.C.J. and Xiang, Z.Q. “Genetic Immunization” Viral Immunology 1996, vol. 9, No. 1:1-9.
van Drunen Little-van den Hurk, S. et al., “Intradernal immunization with a bovine herpesvirus—l DNA vaccine induces protective immunity in cattle” Journal of General Virology 1998, vol. 79:831-839.
Donnelly, J.J., et al., “Immunization with DNA” Journal of Immunological Methods 1994, vol. 176:145-152.
van Rooij, E.M.A., et al., “Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs” Veterinary Immunology and Immunopathology 1998, vol. 66:113-126.
Ulmer, J.B., et al., “Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines” Vaccine 1994, vol. 12, No. 16:1541-1544. (Abstract), Abstract Only.
Andrew, M.E., et al., “Protection of pigs against classical swine fever with DNA-delivered gp55” Vaccine 2000, vol. 18:1932-1938.
Ulmer, J. B., et al., “Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein” Science 1993, vol. 259:1745-1749.
Xiang, Z.Q., et al., “Vaccination with a Plasmid Vector Carrying the Rabies Virus Glycoprotein Gene Induces Protective Immunity against Rabies Virus” Virology 1994, vol. 199:132-140.
Jenkins, M., et al., “Serum and colostrum antibody responses induced by jet-injection of sheep with DNA encodeing aCryptosporidium parvumantigen” Vaccine 1995, vol. 13, No. 17:1658-1664.
Fynan, E.F. et al., “DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations” Proceedings of the National Academy of Sciences, USA 1993, vol. 90:11478-11482.
Robinson, H.L. et al., “Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA” Vaccine 1993, vol. 11, No. 9:957-960.
Zhu, N. et al., “Systemic Gene Expression After Intravenous DNA Delivery into Adult Mice” Science 1993, vol. 261:209-211.
Sixt, N. et al., “Canine Distemper Virus DNA Vaccination Induces Humoral and Cellular Immunity and Protects against a Lethal Intracerebral Challenge” Journal of Virology 1998, vol. 72, No. 11:8472-8476.
Ban, E.M. et al., “Mucosal immunization with DNA encoding influenza hemagglutinin” Vaccine 1997, vol. 15, No. 8:811-813. (Abstract).
Etchart, N. et al., “Class I-restricted CTL induction by mucosal immunization with naked DNA encoding measles virus haemagglutinin” Journal of General Virology 1997, vol. 78:1577-1580.
Gregoridis, G. “Genetic Vaccines: Strategies for Optimization” Pharmaceutical Research 1998, vol. 15, No. 5:661-670.
Ishii, N. et al., “Cationic Liposomes Are a Strong Adjuvant for a DNA Vaccine of Human Immunodeficiency Virus Type 1” AIDS Research and Human Retroviruses 1997, vol. 13, No. 16:1421-1428.
Haddad, D. et al., “Comparative study of DNA-based immunization vectors: effect of secretion signals on the antibody responses in mice” FEMS Immunology and Medical Microbiology 1997, vol. 18:193-202.
Gregoriadis, G. et al., “Liposome-mediated DNA vaccination” FEBS Letters 1997, vol. 402:107-110.
Xiang, Z. and Ertl, H.C.J. “Manipulation of the Immune Response to a Plasmid-Encoded Viral Antigen by Coinoculation with Plasmids Expressing Cytokines” Immunity 1995, vol. 2:129-135.
Choi, A.H.C. et al., “Particle-Bombardment-Mediated DNA Vaccination with Rotavirus VP4 or VP7 Induces High Levels of Serum Rotavirus IgG but Fails to Protect Mice against Challenge” Virology 1998, vol. 250:230-240.
Xu, L. et al., “Immunization for Ebola virus infection” Nature Medicine 1998, vol. 4, No. 1:37-42.
Behr, J.P. “Gene Transfer with Synthetic Cationic Amphiphiles: Prospects for Gene Therapy” Bioconjugate Chemistry 1994, vol. 5, No. 5:382-389.
Naik, S. and Shaila, MS. “Characterization of membrane-bound and membrane anchor-less forms of hemagglutinin glycoprotein of Rinderpest virus expressed by baculovirus recombinants” Virus Genes 1997, vol. 14, No. 2:95-104. (Abstract), Abstract Only.
Nash, R.A. et al., “Molecular cloning and in vivo evaluation of canine granulocyte-macrophage colony-stimulating factor” Blood 1991, vol. 78, No. 4:930-937. (Abstract), Abstract
Audonnet Jean-Christophe Francis
Barzu-Le-Roux Simona
Fischer Laurent Bernard
Angell Jon Eric
Frommer & Lawrence & Haug LLP
Kowalski Thomas J.
Merial
Nguyen Dave T.
LandOfFree
DNA vaccines for farm animals, in particular bovines and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA vaccines for farm animals, in particular bovines and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA vaccines for farm animals, in particular bovines and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3458834